Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10009794HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS10036366HBVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058841HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058842HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058843HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058844HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058845HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058846HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058847HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TVIS30058848HIVENSG00000114200.10protein_codingBCHENoNo590P06276
TCGA Plot Options
Drug Information
GeneBCHE
DrugBank IDDB01057
Drug NameEchothiophate
Target IDBE0002180
UniProt IDP06276
Regulation Typeinhibitor
PubMed IDs2481033; 11752352
CitationsHenderson EG, Post-Munson DJ, Reynolds LS, Epstein PM: Echothiophate and cogeners decrease the voltage dependence of end-plate current decay in frog skeletal muscle. J Pharmacol Exp Ther. 1989 Dec;251(3):810-6.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationTetraalkylammonium salts
SMILESCCOP(=O)(OCC)SCC[N+](C)(C)C
Pathways
PharmGKBPA164743139
ChEMBLCHEMBL1201341